Dermatological lesions near the smallpox vaccination site after scab detachment

Clinical Infectious Diseases

Volumn 46, Issue SUPPL. 3, 2008, Pages

  Kroger, Andrew ^a,h   Vellozzi, Claudia ^b   Deming, Michael ^c   Casey, Christine G ^d   Wen, Xiaojun ^e,f   Norton, Scott A ^g  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Office of the Chief Science Officer   (United States)

^e NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^f NORTHROP GRUMMAN CORPORATION   (United States)

^g Walter Reed Army Medical Center   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE; DRYVAX VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHEMA; FEMALE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; PAPULE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUSTULE; QUESTIONNAIRE; SCABIES; SCAR FORMATION; SKIN DEFECT; SMALLPOX; VACCINIA VIRUS; DRUG SURVEILLANCE PROGRAM; HEALTH CARE PERSONNEL; INCIDENCE; MALE; MASS IMMUNIZATION; MIDDLE AGED; PATHOLOGY; SCAR; SKIN DISEASE; UNITED STATES; VIROLOGY;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CICATRIX; FEMALE; HEALTH PERSONNEL; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MASS IMMUNIZATION; MIDDLE AGED; SENTINEL SURVEILLANCE; SKIN DISEASES; SMALLPOX VACCINE; UNITED STATES;

EID: 41649094443     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/524746     Document Type: Article

References (29)

1. Wharton M, Strikas RA, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52(RR-7):1-16.
2. Grabenstein JD, Winkenwerder W Jr. U.S. military smallpox vaccination program experience. JAMA 2003; 289:3278-82.
3. US Department of Health and Human Services. Declaration regarding administration of smallpox countermeasures. Fed Regist 2003; 68:4212-3.
4. Casey CG, Iskander J, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005; 294:2734-43.
5. Edwards K. Danger of sunburn following vaccination. P N G Med J 1977; 20:203.
6. Ehrengut W. Multiple sclerosis: vesicles at vaccination scar. Lancet 1974; 304:1576.
7. Goncalves JC. Malignant change in smallpox vaccination scars. Arch Dermatol 1966; 93:229-30.
8. Green JJ, Heyman WR. Dermatofibrosarcoma protuberans occurring in a smallpox vaccination scar. J Am Acad Dermatol 2003; 48(Suppl 5):S54-5.
9. Gundersen SG, Bjorvatn B. Vaccinia and topical steroids: a case report. Acta Derm Venereol 1980; 60:445-7.
10. Helman J. Vaccinia as a possible carcinogen. Lancet 1957; 269:50-1.
11. Kulwin MH. Basal cell epithelioma in smallpox vaccination scar - fifty years later. IMJ Ill Med J 1975; 148:612-3.
12. Lupton GP. Discoid lupus erythematosus occurring in a smallpox vaccination scar. J Am Acad Dermatol 1987; 17:688-9.
13. Marmelzat WL, Hirsch P, Martel S. Malignant melanomas in smallpox vaccination scars. Arch Dermatol 1964; 89:823-6.
14. Marmelzat WL. Malignant tumors in smallpox vaccination scars. Arch Dermatol 1968; 97:400-6.
15. Mintz L. Recurrent herpes simplex infection at a smallpox vaccination site. JAMA 1982; 247:2704-5.
16. Onwukwe MF. Cutaneous complications of smallpox vaccination scars. Int J Dermatol 1973; 12:290-4.
17. Pfahlberg A, Kolmel KF, Grange JM, et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. J Invest Dermatol 2002; 119:570-5.
18. Pujol RM, Monmany J, Bague S, Alomar A. Graves' disease presenting as a localized myxoedematous infiltration in a smallpox vaccination scar. Clin Exp Dermatol 2000; 25:132-4.
19. Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1000 patients with keloids in south India. Plast Reconstr Surg 1974; 53:276-80.
20. Sherwood PH. Multiple sclerosis: absence of fever blisters. Lancet 1974; 2:1151.
21. Weary P. Basal cell carcinoma arising at site of smallpox vaccination. Cutis 1967; 10:1114-6.
22. Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol 1995; 34:341-4.
23. Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep 2003; 52(RR-4):1-28.
24. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ 2003; 52:1-24 (erratum: MMWR Morb Mortal Wkly Rep 2003; 52:113).
25. SAS: business intelligence software and predictive analytics. Available at: http://www.sas.com/index.html. Accessed 18 January 2008.
26. Kipreos V. Transcript: data and information management of the smallpox vaccine program, 2002. Available at: http://www.bt.cdc.gov/agent/smallpox/ training/webcast/dec2002/files/data-mgmt-transcript.pdf. Accessed 25 October 2005.
27. Marks R. Squamous cell carcinoma. Lancet 1996; 347:735-8.
28. Grabenstein JD. Immunofacts: vaccines and immunologic drugs. St. Louis: Wolters Kluwer Health, 2004.
29. Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review. Part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions. Clin Infect Dis 2003; 37:241-50.